Cardiac Surgery Using Hypothermic Circulatory Arrest in a Case of Essential Thrombocythemia

We present the case of a 61-year-old patient with a history of essential thrombocythemia (ET) who was diagnosed as having aortic valve stenosis and dilatation of his ascending aorta. His aortic valve and ascending aorta were replaced under hypothermic circulatory arrest (HCA). No clear guideline exists for preoperative, perioperative, and postoperative management of cardiac surgery using HCA for ET patients. After performing risk assessment, we prescribed preoperative aspirin therapy and postoperative care was planned as usual for cardiovascular surgery in our establishment. Unexpectedly, activated clotting time did not exceed 400 seconds, but the course of treatment was otherwise uneventful.

[1]  G. Nuttall,et al.  A Novel Approach to Essential Thrombocythemia and Cardiac Surgery. , 2017, Annals of Thoracic Surgery.

[2]  T. Soeda,et al.  Emergency cardiac surgery and heparin resistance in a patient with essential thrombocythemia , 2016, JA Clinical Reports.

[3]  Tomoya Inoue,et al.  Aortic Valve Replacement in a Patient with Essential Thrombocythemia , 2014 .

[4]  S. Das,et al.  Thrombocytapheresis: managing essential thrombocythemia in a surgical patient. , 2011, The Annals of thoracic surgery.

[5]  P. Campbell,et al.  How I treat essential thrombocythemia. , 2011, Blood.

[6]  H. Endeman,et al.  Cardiac surgery in a patient with essential thrombocythemia: a case report , 2010, Netherlands Heart Journal.

[7]  S. Langley,et al.  Aortic valve replacement in a young patient with essential thrombocytosis , 2008, Journal of cardiothoracic surgery.

[8]  H. Masuhara,et al.  A Case of Coronary Artery Bypass Grafting with Essential Thrombocythemia , 2007 .

[9]  D. Larson,et al.  Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors. , 2006, Mayo Clinic proceedings.

[10]  J. D. van der Walt,et al.  Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia. , 2005, The New England journal of medicine.

[11]  K. Hashimoto,et al.  Aortic Valve Replacement Associated with Essential Thrombocythemia , 2004 .

[12]  Riva,et al.  No treatment for low‐risk thrombocythaemia:results from a prospective study , 1998, British journal of haematology.

[13]  N. Nakajima,et al.  [A case of coronary artery bypass surgery using left internal thoracic artery and right gastroepiploic artery for a patient with essential thrombocythemia]. , 1998, The Japanese Journal of Thoracic and Cardiovascular Surgery.

[14]  H. Nakatani,et al.  [A case report of aorto-coronary artery bypass surgery in patient with essential thrombocythemia]. , 1997, [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai.

[15]  T. Tamiya,et al.  [A case report: mitral valve replacement for the patient with essential thrombocythemia]. , 1993, [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai.

[16]  T. Sato,et al.  [A case report: coronary artery bypass grafting for the patient with essential thrombocythemia]. , 1991, [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai.